866-997-4948(US-Canada Toll Free)

Optometry Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022

Published By :

Transparency Market Research

Published Date : Sep 2017

Category :

Medical Devices

No. of Pages : 182 Pages

Global Optometry Market: Scope and Methodology

This report on the global optometry market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment and sub-segment for the period from 2017 to 2025, considering the macro and micro environmental factors. Growth rates for each segment within the global optometry market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global optometry market.

Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year. Market size estimations involved in-depth study of various segments of global optometry market.

Optometry Market: Segmentation

Optometry is a part of health care sector which deals with measurement of vision or eye sight. Optometrist are healthcare professionals that are licensed and registered to prescribe therapeutics and corrective lenses for faulty vision or eye sight. Globally around 285 million people are visually impaired. These visual impairments can be corrected with proper usage of corrective lenses or an ophthalmology procedure. The optometry market has a huge scope during the forecast period. The global optometry market can be segmented based on product type, distribution channel and region.

Depending on the product type the global optometry market includes therapeutics and vision care equipment. The therapeutics segment consists of anti-inflammatory drugs, anti-fungal drugs, anti-infective drugs, anti-allergy drugs and others. The vision care equipment segment includes eye glasses and contact lenses. Vision care equipment is projected to be a highly attractive segment of the global optometry market during the forecast period. The segment is anticipated to be expand at a CAGR of 4.4% during the forecast period. Eye glasses segment contributes maximum share to the global optometry market in terms of revenue. Increasing importance for fashion accessories is significantly supporting growth of the global optometry market. As eyewear is one of the most accessible and visible accessories with an affordable price, the optometry market is expected to witness significant growth during the forecast period. Based on the distribution channel, the global optometry market is segmented into hospital pharmacies, optometry clinics, optical centers, online and retail stores and others. Optometry clinics is attributed to contribute a significant share to the global optometry market.

Optometry Market: Geographical and Competitive Dynamics

Geographically, the global optometry market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region.

The report also profiles major players in the hereditary angioedema market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Johnson & Johnson Vision Care, Inc., CooperVision, Novartis AG, Pfizer, Inc., Valeant Pharmaceuticals International, Inc., Allergan and Essilor.

The global optometry market is segmented as follows:

Global Optometry Market Revenue, by Product type

  • Therapeutics
    • Anti- Inflammatory Drugs
      • Steroids
      • NSAIDs
    • Anti-fungal Drugs
    • Anti-infective Drugs
    • Anti-allergy Drugs
    • Others
  • Vision Care Equipment
    • Eye Glasses
    • Contact Lenses
      • Soft Contact Lenses
      • Rigid Gas Permeable Lenses
      • Extended Wear Contact Lenses
      • Others

Global Optometry Market Revenue, by Distribution Channel

  • Hospital Pharmacies
  • Online & Retail Stores
  • Optometry Clinics
  • Optical Centres
  • Others

Global Optometry Market Revenue, by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC countries
    • South Africa
    • Rest of Middle East & Africa

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Optometry Market

4. Market Overview
     4.1. Introduction
     4.2. Overview
     4.3. Key Market Indicators
     4.4. Market Dynamics
            4.4.1. Drivers
            4.4.2. Restraints
            4.4.3. Opportunities
     4.5. Global Optometry Market Analysis and Forecasts, 2015–2025
            4.5.1. Market Revenue Projections (US$ Mn)
     4.6. Porter’s Five Force Analysis
     4.7. Market Outlook

5. Global Optometry Market, Analysis and Forecasts, By Product Type
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Market Value Forecast By Product Type, 2015–2025
            5.3.1. Therapeutics
                     5.3.1.1. Anti-Inflammatory Drugs
                                5.3.1.1.1. Steroids
                                5.3.1.1.2. Non-Steroidal
                     5.3.1.2. Anti-Fungal Drugs
                     5.3.1.3. Anti-Infective Drugs
                     5.3.1.4. Anti-Allergy Drugs
                     5.3.1.5. Others
            5.3.2. Vision Care Equipment
                     5.3.2.1. Eyeglasses
                     5.3.2.2. Contact Lenses
                                5.3.2.2.1. Soft Contact lenses
                                5.3.2.2.2. Rigid gas Permeable Contact lenses
                                5.3.2.2.3. Extended Wear Contact lenses
                                5.3.2.2.4. Others
     5.4. Market Attractiveness By Product Type

6. Global Optometry Market Analysis and Forecasts, By Distribution Channel
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Market Value Forecast By Distribution Channel, 2015–2025
            6.3.1. Hospital Pharmacies
            6.3.2. Online Pharmacies & Retail Stores
            6.3.3. Ophthalmology Clinics
            6.3.4. Optical Centers
            6.4.5. Others
     6.5. Market Attractiveness By Distribution Channel

7. Global Optometry Market Analysis and Forecasts, By Region
     7.1. Key Findings
     7.2. Market Value Forecast By Region
            7.2.1. North America
            7.2.2. Europe
            7.2.3. Asia Pacific
            7.2.4. Latin America
            7.2.5. Middle East and Africa
     7.3. Market Attractiveness By Country/Region

8. North America Optometry Market, Analysis and Forecast
     8.1. Introduction
            8.1.1. Key Findings
            8.1.2. Policies and Regulations
     8.2. Market Value Forecast By Country, 2015–2025
            8.2.1. U.S.
            8.2.2. Canada
     8.3. Market Attractiveness By Country
     8.4. Market Value Forecast By Product Type, 2015–2025
            8.4.1. Therapeutics
                     8.4.1.1. Anti-Inflammatory Drugs
                                8.4.1.1.1. Steroids
                                8.4.1.1.2. Non-Steroidal
                     8.4.1.2. Anti-Fungal Drugs
                     8.4.1.3. Anti-Infective Drugs
                     8.4.1.4. Anti-Allergy Drugs
                     8.4.1.5. Others
            8.4.2. Vision Care Equipment
                     8.4.2.1. Eyeglasses
                     8.4.2.2. Contact Lenses
                                8.4.2.2.1. Soft Contact lenses
                                8.4.2.2.2. Rigid gas Permeable Contact lenses
                                8.4.2.2.3. Extended Wear Contact lenses
                                8.4.2.2.4. Others
     8.5. Market Value Forecast By Distribution Channel, 2015–2025
            8.5.1. Hospital Pharmacies
            8.5.2. Online Pharmacies & Retail Stores
            8.5.3. Ophthalmology Clinics
            8.5.4. Optical Centers
            8.5.4. Others

9. Europe Optometry Market, Analysis and Forecast
     9.1. Introduction
            9.1.1. Key Findings
            9.1.2. Policies and Regulations
     9.2. Market Value Forecast By Country, 2015–2025
            9.2.1. U.K.
            9.2.2. Germany
            9.2.3. France
            9.2.4. Italy
            9.2.5. Spain
            9.2.6. Rest of Europe
     9.3. Market Attractiveness By Country
     9.4. Market Value Forecast By Product Type, 2015–2025
            9.4.1. Therapeutics
                     9.4.1.1. Anti-Inflammatory Drugs
                                9.4.1.1.1. Steroids
                                9.4.1.1.2. Non-Steroidal
                     9.4.1.2. Anti-Fungal Drugs
                     9.4.1.3. Anti-Infective Drugs
                     9.4.1.4. Anti-Allergy Drugs
                     9.4.1.5. Others
            9.4.2. Vision Care Equipment
                     9.4.2.1. Eyeglasses
                     9.4.2.2. Contact Lenses
                                9.4.2.2.1. Soft Contact lenses
                                9.4.2.2.2. Rigid gas Permeable Contact lenses
                                9.4.2.2.3. Extended Wear Contact lenses
                                9.4.2.2.4. Others
     9.5. Market Value Forecast By Distribution Channel, 2015–2025
            9.5.1. Hospital Pharmacies
            9.5.2. Online Pharmacies & Retail Stores
            9.5.3. Ophthalmology Clinics
            9.5.4. Optical Centers
            9.5.4. Others

10. Asia Pacific Optometry Market, Analysis and Forecast
     10.1. Introduction
            10.1.1. Key Findings
            10.1.2. Policies and Regulations
     10.2. Market Value Forecast By Country, 2015–2025
            10.2.1. Japan
            10.2.2. China
            10.2.3. India
            10.2.4. Australia & New Zealand
            10.2.5. Rest of Asia Pacific
     10.3. Market Attractiveness By Country
     10.4. Market Value Forecast By Product Type, 2015–2025
            10.4.1. Therapeutics
                     10.4.1.1. Anti-Inflammatory Drugs
                                10.4.1.1.1. Steroids
                                10.4.1.1.2. Non-Steroidal
                     10.4.1.2. Anti-Fungal Drugs
                     10.4.1.3. Anti-Infective Drugs
                     10.4.1.4. Anti-Allergy Drugs
                     10.4.1.5. Others
            10.4.2. Vision Care Equipment
                     10.4.2.1. Eyeglasses
                     10.4.2.2. Contact Lenses
                                10.4.2.2.1. Soft Contact lenses
                                10.4.2.2.2. Rigid gas Permeable Contact lenses
                                10.4.2.2.3. Extended Wear Contact lenses
                                10.4.2.2.4. Others
     10.5. Market Value Forecast By Distribution Channel, 2015–2025
            10.5.1. Hospital Pharmacies
            10.5.2. Online Pharmacies & Retail Stores
            10.5.3. Ophthalmology Clinics
            10.5.4. Optical Centers
            10.5.5. Others

11. Latin America Optometry Market, Analysis and Forecast
     11.1. Introduction
            11.1.1. Key Findings
            11.1.2. Policies and Regulations
     11.2. Market Value Forecast By Country, 2015–2025
            11.2.1. Brazil
            11.2.2. Mexico
            11.2.3. Rest of Latin America
     11.3. Market Attractiveness By Country
     11.4. Market Value Forecast By Product Type, 2015–2025
            11.4.1. Therapeutics
                     11.4.1.1. Anti-Inflammatory Drugs
                                11.4.1.1.1. Steroids
                                11.4.1.1.2. Non-Steroidal
                     11.4.1.2. Anti-Fungal Drugs
                     11.4.1.3. Anti-Infective Drugs
                     11.4.1.4. Anti-Allergy Drugs
                     11.4.1.5. Others
            11.4.2. Vision Care Equipment
                     11.4.2.1. Eyeglasses
                     11.4.2.2. Contact Lenses
                                11.4.2.2.1. Soft Contact lenses
                                11.4.2.2.2. Rigid gas Permeable Contact lenses
                                11.4.2.2.3. Extended Wear Contact lenses
                                11.4.2.2.4. Others
     11.5. Market Value Forecast By Distribution Channel, 2015–2025
            11.5.1. Hospital Pharmacies
            11.5.2. Online Pharmacies & Retail Stores
            11.5.3. Ophthalmology Clinics
            11.5.4. Optical Centers
            11.5.4. Others

12. Middle East & Africa Optometry Market, Analysis and Forecast
     12.1. Introduction
            12.1.1. Key Findings
            12.1.2. Policies and Regulations
     12.2. Market Value Forecast By Country, 2015–2025
            12.2.1. GCC Countries
            12.2.2. South Africa
            12.2.3. Rest of MEA
     12.3. Market Attractiveness By Country
     12.4. Market Value Forecast By Product Type, 2015–2025
            12.4.1. Therapeutics
                     12.4.1.1. Anti-Inflammatory Drugs
                                12.4.1.1.1. Steroids
                                12.4.1.1.2. Non-Steroidal
                     12.4.1.2. Anti-Fungal Drugs
                     12.4.1.3. Anti-Infective Drugs
                     12.4.1.4. Anti-Allergy Drugs
                     12.4.1.5. Others
            12.4.2. Vision Care Equipment
                     12.4.2.1. Eyeglasses
                     12.4.2.2. Contact Lenses
                                12.4.2.2.1. Soft Contact lenses
                                12.4.2.2.2. Rigid gas Permeable Contact lenses
                                12.4.2.2.3. Extended Wear Contact lenses
                                12.4.2.2.4. Others
     12.5. Market Value Forecast By Distribution Channel, 2015–2025
            12.5.1. Hospital Pharmacies
            12.5.2. Online Pharmacies & Retail Stores
            12.5.3. Ophthalmology Clinics
            12.5.4. Optical Centers
            12.5.4. Others

13. Competition Landscape
     13.1. Company Share Analysis By Company (2016)
     13.2. Company Profiles
            13.2.1. CooperVision
                     13.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.1.2. Financial Overview
                     13.2.1.3. Product Portfolio
                     13.2.1.4. SWOT Analysis
                     13.2.1.5. Strategic Overview
            13.2.2. Johnson & Johnson Vision Care, Inc.
                     13.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.2.2. Financial Overview
                     13.2.2.3. Product Portfolio
                     13.2.2.4. SWOT Analysis
                     13.2.2.5. Strategic Overview
            13.2.3. Carl Zeiss
                     13.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.3.2. Financial Overview
                     13.2.3.3. Product Portfolio
                     13.2.3.4. SWOT Analysis
                     13.2.3.5. Strategic Overview
            13.2.4. Novartis AG
                     13.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.4.2. Financial Overview
                     13.2.4.3. Product Portfolio
                     13.2.4.4. SWOT Analysis
                     13.2.4.5. Strategic Overview
            13.2.5. Essilor
                     13.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.5.2. Financial Overview
                     13.2.5.3. Product Portfolio
                     13.2.5.4. SWOT Analysis
                     13.2.5.5. Strategic Overview
            13.2.6. Valeant Pharmaceuticals International, Inc. (Bausch+Lomb Incorporated)
                     13.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.6.2. Financial Overview
                     13.2.6.3. Product Portfolio
                     13.2.6.4. SWOT Analysis
                     13.2.6.5. Strategic Overview
            13.2.7. ALLERGAN
                     13.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.7.2. Financial Overview
                     13.2.7.3. Product Portfolio
                     13.2.7.4. SWOT Analysis
                     13.2.7.5. Strategic Overview
            13.2.8. Pfizer, Inc.
                     13.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.8.2. Financial Overview
                     13.2.8.3. Product Portfolio
                     13.2.8.4. SWOT Analysis
                     13.2.8.5. Strategic Overview
            13.2.9. F. Hoffmann-La Roche Ltd.
                     13.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.9.2. Financial Overview
                     13.2.9.3. Product Portfolio
                     13.2.9.4. SWOT Analysis
                     13.2.9.5. Strategic Overview
            13.2.10. Transitions Optical Limited
                     13.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.10.2. Financial Overview
                     13.2.10.3. Product Portfolio
                     13.2.10.4. SWOT Analysis
                     13.2.10.5. Strategic Overview
            13.2.11. HOYA GROUP
                     13.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.11.2. Financial Overview
                     13.2.11.3. Product Portfolio
                     13.2.11.4. SWOT Analysis
                     13.2.11.5. Strategic Overview
            13.2.12. CIRON Drugs & Pharmaceuticals Pvt. Ltd.
                     13.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.12.2. Financial Overview
                     13.2.12.3. Product Portfolio
                     13.2.12.4. SWOT Analysis
                     13.2.12.5. Strategic Overview
            13.2.13. NIDEK CO., LTD.
                     13.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.13.2. Financial Overview
                     13.2.13.3. Product Portfolio
                     13.2.13.4. SWOT Analysis
                     13.2.13.5. Strategic Overview
            13.3.14. TOPCON CORPORATION
                     13.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.14.2. Financial Overview
                     13.2.14.3. Product Portfolio
                     13.2.14.4. SWOT Analysis
                     13.2.14.5. Strategic Overview
            13.2.15. GrandVision
                     13.2.15.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.15.2. Financial Overview
                     13.2.15.3. Product Portfolio
                     13.2.15.4. SWOT Analysis
                     13.2.15.5. Strategic Overview

List of Table

List of Table

Table 01: Global estimate of the number of people visually impaired by age (2010)
Table 02: Global Optometry Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 03: Global Optometry Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 04: Global Optometry Market Size (US$ Mn) Forecast, by Anti-inflammatory Drugs, 2015–2025
Table 05: Global Optometry Market Size (US$ Mn) Forecast, by Vision Care Equipment, 2015–2025
Table 06: Global Optometry Market Size (US$ Mn) Forecast, by Contact Lenses, 2015–2025
Table 07: Global Optometry Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 08: Global Optometry Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 09: North America Optometry Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 10: North America Optometry Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 11: North America Optometry Market Size (US$ Mn) Forecast, by Product Type – Therapeutics, 2015–2025
Table 12: North America Optometry Market Size (US$ Mn) Forecast, by Therapeutics – Anti-inflammatory Drugs, 2015–2025
Table 13: North America Optometry Market Size (US$ Mn) Forecast, by Product Type – Vision Care Equipment, 2015–2025
Table 14: North America Optometry Market Size (US$ Mn) Forecast, by Vision Care Equipment – Contact Lenses, 2015–2025
Table 15: North America Optometry Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 16: Europe Optometry Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 17: Europe Optometry Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 18: Europe Optometry Market Size (US$ Mn) Forecast, by Product Type – Therapeutics, 2015–2025
Table 19: Europe Optometry Market Size (US$ Mn) Forecast, by Therapeutics – Anti-inflammatory Drugs, 2015–2025
Table 20: Europe Optometry Market Size (US$ Mn) Forecast, by Product Type – Vision Care Equipment, 2015–2025
Table 21: Europe Optometry Market Size (US$ Mn) Forecast, by Vision Care Equipment – Contact Lenses, 2015–2025
Table 22: Europe Optometry Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 23: Asia Pacific Optometry Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 24: Asia Pacific Optometry Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 25: Asia Pacific Optometry Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 26: Asia Pacific Optometry Market Size (US$ Mn) Forecast, by Anti-inflammatory Drugs, 2015–2025
Table 27: Asia Pacific Optometry Market Size (US$ Mn) Forecast, by Vision Care Equipment, 2015–2025
Table 28: Asia Pacific Optometry Market Size (US$ Mn) Forecast, by Contact Lenses, 2015–2025
Table 29: Asia Pacific Optometry Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 30: Latin America Optometry Market Size (US$ Mn) Forecast, by Country, 2015 -2025
Table 31: Latin America Optometry Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 32: Latin America Optometry Market Size (US$ Mn) Forecast, by Product Type – Therapeutics, 2015–2025
Table 33: Latin America Optometry Market Size (US$ Mn) Forecast, by Therapeutics – Anti-inflammatory Drugs, 2015–2025
Table 34: Latin America Optometry Market Size (US$ Mn) Forecast, by Product Type – Vision Care Equipment, 2015–2025
Table 35: Latin America Optometry Market Size (US$ Mn) Forecast, by Vision Care Equipment – Contact Lenses, 2015–2025

List of Chart

List of Figures

Figure 01: Global Optometry market, by Product Type, Market Size (US$ Mn), 2016 (A)
Figure 02: Optometry market revenue (%), by top three segments, 2016 (A)
Figure 03: Executive Summary (2/3)
Figure 04: Executive Summary (3/3)
Figure 05: Opportunity Map, 2017
Figure 06: Opportunity Map, 2017
Figure 07: Key Industry Developments
Figure 09: Percentage of eye major eye diseases in the world
Figure 08: Global Optometry Market Size (US$ Mn) Forecast, 2015–2025
Figure 10: Global Optometry Market Value Share, by Product, 2017 and 2025
Figure 11: Global Optometry Market Attractiveness, by Product, 2017–2025
Figure 12: Global Optometry Market Value Share, by Therapeutics, 2017 and 2025
Figure 13: Global Optometry Market Attractiveness, by Therapeutics, 2017–2025
Figure 14: Global Optometry Market Value Share, by Vision Care Equipment, 2017 and 2025
Figure 15: Global Optometry Market Attractiveness, by Vision Care Equipment, 2017–2025
Figure 16: Global Optometry Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Anti-inflammatory Drugs, 2015–2025
Figure 17: Global Optometry Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Anti-fungal Drugs, 2015–2025
Figure 18: Global Optometry Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Anti-infective Drugs, 2015–2025
Figure 19: Global Optometry Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Anti-allergy Drugs, 2015–2025
Figure 20: Global Optometry Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2015–2025
Figure 21: Global Optometry Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Eye Glasses, 2015–2025
Figure 22: Global Optometry Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Contact Lenses, 2015–2025
Figure 23: Global Optometry Market Value Share, by Distribution Channel, 2017 and 2025
Figure 24: Global Optometry Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacies, 2015–2025
Figure 25: Global Optometry Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Online & Retail Stores, 2015–2025
Figure 26: Global Optometry Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Optometry Clinics, 2015–2025
Figure 27: Global Optometry Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Optical Centers, 2015–2025
Figure 28: Global Optometry Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2015–2025
Figure 29: Global Optometry Market Attractiveness, by Distribution Channel, 2017–2025
Figure 30: Global Market Scenario
Figure 31: Global Optometry Market Value Share, by Region, 2017 and 2025 
Figure 32: Global Optometry Market Attractiveness, by Region, 2017–2025
Figure 33: North America Optometry Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 34: North America Optometry Market Attractiveness Analysis, by Country, 2017–2025
Figure 35: North America Optometry Market Value Share Analysis, by Country, 2017 and 2025
Figure 36: North America Optometry Market Value Share, by Product Type, 2017 and 2025
Figure 37: North America Optometry Market Attractiveness Analysis, by Product Type, 2017–2025
Figure 38: North America Optometry Market Value Share, by Therapeutics, 2017 and 2025
Figure 39: North America Optometry Market Value Share, by Vision Care Equipment, 2017 and 2025
Figure 40: North America Optometry Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 41: Europe Optometry Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 42: Europe Optometry Market Attractiveness Analysis, by Country, 2017–2025
Figure 43: Europe Optometry Market Value Share Analysis, by Country, 2017 and 2025
Figure 44: Europe Optometry Market Value Share, by Product Type, 2017 and 2025
Figure 45: Europe Optometry Market Attractiveness Analysis, by Product Type, 2017–2025
Figure 46: Europe Optometry Market Value Share, by Therapeutics, 2017 and 2025
Figure 47: Europe Optometry Market Value Share, by Vision Care Equipment, 2017–2025
Figure 48: Europe Optometry Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 49: Asia Pacific Optometry Market Size (US$ Mn) Forecast, and Y-o-Y Growth (%) Projection, 2015–2025
Figure 50: Asia Pacific Optometry Market Attractiveness, by Country
Figure 51: Asia Pacific Optometry Market Value Share Analysis, by Country, 2017 and 2025
Figure 52: Asia Pacific Optometry Market Value Share, by Product, 2017 and 2025
Figure 53: Asia Pacific Optometry Market Attractiveness, by Product
Figure 54: Asia Pacific Optometry Market Value Share, by Therapeutics, 2017 and 2025
Figure 55: Asia Pacific Optometry Market Value Share, by Vision Care Equipment, 2017–2025
Figure 56: Asia Pacific Optometry Market Value Share, by Distribution Channel, 2017 and 2025
Figure 57: Latin America Optometry Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 58: Latin America Optometry Market Attractiveness Analysis, by Country, 2017-2025
Figure 59: Latin America Market Value Share Analysis, by Country, 2017 and 2025
Figure 60: Latin America Optometry Market Value Share Analysis, by Product Type, 2017 and 2025
Figure 61: Latin America Optometry Market Attractiveness Analysis, by Product Type, 2017 -2025
Figure 62: Latin America Optometry Market Value Share, by Product Type – Therapeutics, 2017 and 2025
Figure 63: Latin America Optometry Market Value Share, by Product Type – Vision Care Equipment, 2017 and 2025
Figure 64: Latin America Optometry Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 65: Middle East & Africa Optometry Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
Figure 66: Middle East & Africa Optometry Market Attractiveness, by Country, 2017–2025
Figure 67: Middle East & Africa Optometry Market Value Share Analysis, by Country, 2017 and 2025
Figure 68: Middle East & Africa Optometry Market Value Share, by Product, 2017 and 2025
Figure 69: Middle East & Africa Optometry Market Attractiveness, by Product
Figure 70: Middle East & Africa Optometry Market Value Share, by Therapeutics, 2017 and 2025
Figure 71: Middle East & Africa Optometry Market Value Share, by Vision Care Equipment, 2017–2025
Figure 72: Middle East & Africa Optometry Market Value Share, by Distribution Channel, 2017 and 2025
Figure 73: Global Optometry Market Share, by Therapeutics Segment, by Company, 2016
Figure 74: Global Optometry Market Share, by Vision Care Equipment Segment, by Company, 2016
Figure 75: Breakdown of Net Sales, by Region, 2016
Figure 76: Revenue (US$ Bn) and Y-o-Y Growth (%), The Cooper Companies, Inc., 2013–2016
Figure 77: Breakdown of Net Sales (Johnson & Johnson Services, Inc.), by Segment, 2016
Figure 78: Revenue (US$ Bn) and Y-o-Y Growth (%), Johnson & Johnson Services, Inc., 2013–2016
Figure 79: Breakdown of Net Sales, Carl Zeiss, by Business Segment, 2016
Figure 80: Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016, Carl Zeiss 
Figure 81: Breakdown of Net Sales, Novartis AG, by Region, 2016
Figure 82: Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016, Novartis AG 
Figure 83: Breakdown of Revenue, Essilor, by Business, 2016
Figure 84: Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016, Essilor
Figure 85: Breakdown of Net Sales, Valeant Pharmaceuticals International, Inc., by Business Segment, 2016
Figure 86: Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016, Valeant Pharmaceuticals International, Inc.
Figure 87: Breakdown of Net Sales, ALLERGAN by Segments, 2016
Figure 88: Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016, ALLERGAN
Figure 89: Breakdown of Net Sales, Pfizer, Inc., by Region, 2016
Figure 90: Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016, Pfizer, Inc. 
Figure 91: Breakdown of Net Sales, F. Hoffmann-La Roche Ltd., by Region, 2016
Figure 92: Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016, F. Hoffmann-La Roche Ltd. 
Figure 93: (Essilor) Breakdown of Net Sales, by Business Segment, 2016
Figure 94: (Essilor) Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
Figure 95: Breakdown of Net Sales, TOPCON CORPORATION, by Business Segment, 2015
Figure 96: Eye Care Segment Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2017, TOPCON CORPORATION 
Figure 97: Breakdown of Net Sales, GrandVision, by Region, 2016
Figure 98: Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016, GrandVision

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *